Santa Rosa, CA, Dec. 23rd, 2019 – Convergence Laboratories is excited to announce that after a three-year journey, they have officially received a Type 8 Testing Laboratory license to operate in the state of California from the Bureau of Cannabis Control. BCC License #C8-0000116-LIC was formally issued to Convergence Laboratories on December 23rd, 2019. This license takes precedence over their previously awarded temporary license and allows Convergence Laboratories to “offer or perform testing of cannabis goods to manufacturers, individuals, and distributors in the state. In addition to licensing, Type 8 laboratories are required to obtain ISO/IEC 17025 accreditation.

The company, which provides valuable testing of cannabinoid-based products to patients and consumers in the state of California, operates in Santa Rosa, Sonoma County with an additional location opening in 2020 in Salinas, Monterey County. The comprehensive services provided by Convergence Laboratories are one of the most vital ancillary businesses catering to the hemp and cannabis sectors today. It is through services such as the ones offered by Convergence Laboratories that brands can ensure the quality and potency of their products, and consumers can be assured the purity of what they are consuming.

According to co-founder and CEO Nicole Griffith Barbieri, “To me, this industry isn’t about being the first or the biggest. It’s about being true to oneself, your ideas and focused on the vision. Timing, perseverance and integrity has brought Convergence Laboratories to life. I would like to thank everyone who supported us and worked so hard to get to this point. I am excited to see what the future holds.”